Klara Dickinson

2019 - Cymabay Therapeutics

In 2019, Klara Dickinson earned a total compensation of $1.2M as Chief Regulatory and Compliance Officer at Cymabay Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$72,804
Option Awards$795,418
Salary$364,018
Other$5,014
Total$1,237,254

Dickinson received $795.4K in option awards, accounting for 64% of the total pay in 2019.

Dickinson also received $72.8K in non-equity incentive plan, $364K in salary and $5K in other compensation.

Rankings

In 2019, Klara Dickinson's compensation ranked 8,274th out of 13,971 executives tracked by ExecPay. In other words, Dickinson earned more than 40.8% of executives.

ClassificationRankingPercentile
All
8,274
out of 13,971
41st
Division
Manufacturing
3,270
out of 5,701
43rd
Major group
Chemicals And Allied Products
1,238
out of 2,200
44th
Industry group
Drugs
1,052
out of 1,886
44th
Industry
Pharmaceutical Preparations
781
out of 1,398
44th
Source: SEC filing on May 15, 2020.

Dickinson's colleagues

We found four more compensation records of executives who worked with Klara Dickinson at Cymabay Therapeutics in 2019.

2019

Sujal Shah

Cymabay Therapeutics

Chief Executive Officer

2019

Janet Dorling

Cymabay Therapeutics

Former Chief Commercial Officer

2019

Pol Boudes

Cymabay Therapeutics

Chief Medical Officer

2019

Charles McWherter

Cymabay Therapeutics

Chief Scientific Officer

News

In-depth

You may also like